Stephens Reiterates Buy Rating for Trinity Biotech plc

Stephens Reiterates Buy Rating for Trinity Biotech plc


's stock had its "buy" rating reiterated by equities research analysts at Stephens in a research report issued on Saturday, MarketBeat reports. Several hedge funds and institutional investors recently made changes to their positions in TRIB.



from Biotech News